4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000101
EVP, Chief Scientific Officer sold 848 shares at $480.95 ($407,846)
- EVP, Chief Scientific Officer gave up 3,971 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ALTSHULER DAVID · EVP, Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-24 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −3,971 | $483.28 | $1,919,105 | 41,048 | D |
| 2025-02-25 | Sale : show line 2 in the form 10b5-1 | −848 | $480.95 | $407,846 | 40,200 | D |
| Open-market sales · 848 sh · avg $480.95 · $407,846 | ||||||
Loading xslF345X05/wk-form4_1740603887.xml…